Endocrine responses to ghrelin in adult patients with isolated childhood-onset growth hormone deficiency

Clinical Endocrinology

Volumn 56, Issue 6, 2002, Pages 765-771

  Aimaretti, Gianluca ^a   Baffoni, Claudia ^a   Broglio, Fabio ^a   Janssen, Joop A M ^b   Corneli, Ginevra ^a   Deghenghi, Romano ^c   Van Der Lely, Aart Jan ^b   Ghigo, Ezio ^a   Arvat, Emanuela ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c Ardana   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CORTICOTROPIN; GHRELIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HYDROCORTISONE; INSULIN; PROLACTIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN RELEASE; DRUG EFFECT; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HORMONE RELEASE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYPOGLYCEMIA; MALE; ONSET AGE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE;

ADRENOCORTICOTROPIC HORMONE; ADULT; AGE OF ONSET; AREA UNDER CURVE; ARGININE; CASE-CONTROL STUDIES; GROWTH HORMONE; GROWTH HORMONE-RELEASING HORMONE; HUMANS; HYDROCORTISONE; INSULIN; INSULIN-LIKE GROWTH FACTOR I; MALE; PEPTIDE HORMONES; PEPTIDES; PROLACTIN; STIMULATION, CHEMICAL;

EID: 0036064740     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2002.01547.x     Document Type: Article

References (44)

1. Comparison between insulin-induced hypoglycaemia (ITT) and GHRH + arginine as provocative tests for the diagnosis of GH deficiency (GHD) in adults
2. Comparisons among old and new provocative tests of GH secretion in 178 normal adults
3. Modulation of growth hormone-releasing activity of hexarelin in man
4. Hormonal activities of growth hormone secretagogues (GHS) across a human life-span
5. Preliminary evidence that ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans
6. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: Comparison and interactions with Hexarelin, a non-natural peptidyl GHS, and GH-realising hormone
7. Identification and characterisation of a new growth hormone-releasing peptide receptor in the heart
8. Effect of human pancreatic tumor GH-releasing factor on GH and somatomedin levels in patients with idiopathic GH deficiency
9. Unnatural growth hormone-releasing peptide begets natural ghrelin
10. Atypical growth hormone releasing peptides
11. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycaemia and reduces insulin secretion in humans
12. Physiology of growth hormone secretion and action
13. Growth hormone secretagogues: Physiological role and clinical utility
14. Identification, characterisation, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines
15. Growth hormone-releasing peptides
16. Endocrine and non-endocrine activities of growth hormone secretagogues in humans
17. The regulation of growth hormone secretion
18. Growth hormone-releasing hormone combined with arginine or growth hormone secretagogues for the diagnosis of growth hormone deficiency in adults
19. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human
20. Pituitary adenylate cyclase activating polypeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptors
21. Growth hormone (GH)-releasing factor in GH deficiency: Demonstration of a hypothalamic defect in GH release
22. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency. Statement of the GRS workshop on adult GHD
23. Mediation by the central nervous system is critical to the in vivo activity of the GH secretagogue L-692,585
24. Diagnosis of growth hormone deficiency in adults
25. Purification and characterisation of rat des-Gln14-ghrelin, a second endogenous ligand for the growth hormone secretagogue receptor
26. Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy
27. Ghrelin is a growth-hormone-releasing acylated peptide from stomach
28. Ghrelin: Discovery of the natural endogenous ligand for the growth hormone secretagogue receptor
29. The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants
30. Selective lack of growth hormone (GH) response to the GH-releasing peptide hexarelin in patients with GH-releasing hormone receptor deficiency
31. Interaction of the growth hormone realeasing peptide hexarelin with somatostatin
32. Growth hormone-releasing peptides and the cardiovascular system
33. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers
34. Growth hormone (GH)-releasing peptide-6 requires endogenous hypothalamic GH-releasing hormone for maximal GH stimulation
35. Growth hormone secretagogue binding sites in peripheral human tissues
36. Ghrelin-induced growth hormone secretion in humans
37. Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamo-pituitary disconnection: Evidence that GHRP-6 main action is exerted at the hypothalamic level
38. Control of growth hormone (GH) secretagogues
39. The diagnosis of growth hormone deficiency in children and in adults
40. Peptidomimetic regulation of growth hormone secretion
41. Ghrelin strongly stimulates growth hormone release in humans
42. Activation of the hypotalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue. GH-releasing peptide-6, in rats
43. Ghrelin induces adiposity in rodents
44. A double bind placebo-controlled efficacy trial of an oral growth hormone (GH) secretagogue (MK-0677) in GH deficiency (GHD) children